Trial intelligence / Profile preview

Additional treatment to primary PCI: effects of ischemic postconditioning and Exenatide

2009-011158-17Phase 4Completed

Sponsor
Erasmus MC
Start
Apr 2009
Modality
Peptides
Countries
1
01

Overview

Phase 4 trial of exenatide in myocardial infarction (MI), sponsored by Erasmus MC. Started Apr 2009; status: completed.

02

Drugs

exenatide
03

Conditions

myocardial infarction (MI)

Beyond the preview

Go deeper on 2009-011158-17.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2009-011158-17.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call